[HTML][HTML] Lung cancer and oncolytic virotherapy——enemy's enemy

Z Li, Z Feiyue, L Gaofeng, L Haifeng - Translational Oncology, 2023 - Elsevier
Lung cancer is one of the malignant tumors that seriously threaten human health worldwide,
while the covid-19 virus has become people's nightmare after the coronavirus pandemic …

Temozolomide enhances triple-negative breast cancer virotherapy in vitro

R Garza-Morales, R Gonzalez-Ramos, A Chiba… - Cancers, 2018 - mdpi.com
Triple-negative breast cancer (TNBC) is one of the most aggressive types of cancer, and
treatment is limited to chemotherapy and radiation. Oncolytic virotherapy may be a …

Targeting palbociclib-resistant estrogen receptor-positive breast cancer cells via oncolytic virotherapy

N Lypova, L Lanceta, A Gipson, S Vega… - Cancers, 2019 - mdpi.com
While clinical responses to palbociclib have been promising, metastatic breast cancer
remains incurable due to the development of resistance. We generated estrogen receptor …

Vaccines and Oncolytic Virus for the Treatment of Lung Cancer

AK Dhar, NN Palei, DR Kandula - Immunotherapy Against Lung Cancer …, 2024 - Springer
Lung cancer is the most prevalent cause of cancer deaths in men and women, with a 5-year
survival rate of fewer than 15% due to late-stage diagnosis and ineffective treatments …

Adenovirus with DNA packaging gene mutations increased virus release

SL Wechman, XM Rao, KM McMasters, HS Zhou - Viruses, 2016 - mdpi.com
Adenoviruses (Ads) have been extensively manipulated for the development of cancer
selective replication, leading to cancer cell death or oncolysis. Clinical studies using E1 …

Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis

R Garza-Morales, K Yaddanapudi… - Cancer Biology & …, 2018 - Taylor & Francis
The preclinical evaluation of oncolytic adenoviruses (OAds) has been limited to cancer
xenograft mouse models because OAds replicate poorly in murine cancer cells. The …

The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy

SL Wechman, XM Rao… - Cancer Biology & …, 2018 - Taylor & Francis
Oncolytic adenoviruses (Ads) are cancer selective tumoricidal agents; however their
mechanism of Ad-mediated cancer cell lysis, or oncolysis, remains undefined. This report …

Experimental virus evolution in cancer cell monolayers, spheroids, and tissue explants

A Al-Zaher, P Domingo-Calap, R Sanjuan - Virus Evolution, 2021 - academic.oup.com
Viral laboratory evolution has been used for different applications, such as modeling viral
emergence, drug-resistance prediction, and therapeutic virus optimization. However, these …

Characterization of a mutant oncolytic adenovirus and the role of jnk in enhancing virotherapy.

SL Wechman - 2017 - ir.library.louisville.edu
Oncolytic adenoviruses (Ads) have great therapeutic potential for lung cancer treatment.
Cancer selective E1b-deleted Ads are safe; however, their clinical cancer therapeutic …